Business Context and Reporting Period
This Form 8-K, filed on April 4, 2022, reports events occurring on March 31, 2022, involving Virgin Group Acquisition Corp. II ("VGAC II") and Grove Collaborative, Inc. ("Grove"). The filing details the entry into a Material Definitive Agreement and an amendment to the previously announced merger agreement to facilitate a business combination.
Key Financial Metrics and Transaction Terms
The filing outlines a two-tranche private investment in public equity (PIPE) transaction with Corvina Holdings, Limited (an affiliate of the Sponsor):
- Tranche 1 Investment: $27,500,000 aggregate purchase price for Grove common stock at $11.70 per share.
- Tranche 2 Investment: Commitment to purchase VGAC Class A Common Shares at $10.00 per share. The aggregate amount is calculated as $22,500,000 minus the "Available Cash" remaining in the Trust Account immediately prior to the closing of the Business Combination.
- Warrant Issuance: Post-closing, VGAC II will issue warrants to the Investor exercisable at $0.01 per share. The quantity is based on a formula involving 0.75% plus 1.25% multiplied by the ratio of Post-Combination VGAC Shares to 5,000,000.
- Price Protection: If the volume-weighted average price (VWAP) of VGAC shares falls below $10.00 during a specific 10-day measurement period post-closing, the Investor is entitled to additional shares.
The filing does not provide Grove's historical revenue, profit, cash flow, or debt metrics, as this is a transactional filing rather than a periodic financial report.
Material Changes and Agreements
Several material agreements were executed or amended on March 31, 2022:
- Subscription Agreement: Formalized the PIPE investment described above.
- Amended and Restated Merger Agreement: Replaces the December 7, 2021 agreement. It structures the transaction as a two-step merger (Initial Merger and Final Merger) following the redomestication of VGAC II as a Delaware public benefit corporation.
- Waiver of Cash Condition: Grove agreed to waive the available cash condition in the original Merger Agreement upon payment of the Tranche 1 and Tranche 2 shares.
- Sponsor Agreement Amendment: Modified to state that Sponsor shares will not be subject to earn-out provisions.
- Support Agreement Amendment: Certain Grove stockholders agreed to vote in favor of the amended merger agreement.
Outlook, Risks, and Contingencies
Outlook and Management Commentary: The transaction is contingent upon shareholder approval, regulatory approvals, and the effectiveness of the registration statement on Form S-4. Management expects the business combination to proceed subject to these conditions.
Risks and Contingencies:
- Termination Provisions: If the Merger Agreement is terminated without completion, Tranche 1 Shares may convert to preferred stock, Grove may face repurchase obligations, and the Investor may receive warrants exercisable for Grove stock.
- Forward-Looking Statements: The filing includes standard disclaimers regarding risks such as product acceptance, capital sufficiency, and regulatory hurdles that could cause actual results to differ from projections.
- Unregistered Securities: The shares offered in the PIPE transaction are unregistered, relying on Section 4(a)(2) of the Securities Act.
Investor Verification Checklist
- Verify the final "Available Cash" in the Trust Account to determine the exact size of the Tranche 2 investment.
- Review the definitive proxy statement/prospectus (Form S-4) for detailed risk factors and financial projections for Grove.
- Confirm the final Exchange Ratio and the number of Tranche 1 Shares to be issued prior to closing.
- Monitor the status of the Form S-4 registration statement effectiveness and shareholder voting results.
- Assess the impact of the waived cash condition on the post-merger capital structure.